Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy treatment involves a once-weekly semaglutide injection that reduces appetite — but what you eat while taking it shapes how well the treatment works and how you feel day to day. Most people find their hunger drops noticeably, especially in the first few weeks, and that shift needs a plan. Semaglutide is a prescription-only medicine; a clinician assesses suitability before any treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine it's two days after your second Wegovy injection. You've made dinner, sat down, eaten four forkfuls, and genuinely cannot face the rest of the plate. That's not a side effect to push through, it's the medicine doing exactly what it's licensed to do. Semaglutide slows how quickly your stomach empties and signals to the brain that you're satisfied sooner. For many people this is the first time in years that hunger has felt optional.
The risk in those early weeks is under-eating to the point where you're running on very little protein and not much else. Lean protein (eggs, fish, chicken, Greek yoghurt, legumes) should anchor every meal you do eat, even if that meal is small. Protein preserves muscle tissue when your overall calorie intake falls, and muscle is the tissue that keeps your metabolism ticking. Aim to get some protein at every eating occasion, not just dinner.
Soft, easily digested foods tend to sit better in the early weeks. Plain rice, soups, soft-cooked vegetables and oats are forgiving. Very fatty or very spicy food can worsen the nausea and reflux that some people experience after starting or after a dose step-up, so it's worth cutting those back temporarily rather than waiting to see. The dedicated guide to eating on Wegovy goes deeper on practical meal ideas. The NHS semaglutide medicines page also outlines which side effects are common and when to seek help.
A few months in, most people have found a rhythm. Appetite is settled at a new, lower level. This is the phase where the Wegovy treatment plan starts to feel sustainable, and it's also where nutritional gaps can quietly develop if you're not paying attention.
Fibre is the one people underestimate. When gastric emptying slows and overall food volume drops, constipation becomes a genuine issue for many patients, it's one of the most commonly reported complaints beyond the initial nausea. Vegetables, whole grains, lentils and flaxseed all help, as does consistent water intake throughout the day. A quick practical check: if your urine is a dark yellow by mid-morning, you're probably not drinking enough, aim for pale straw. That's a habit you can assess in under a minute, and it matters more on this treatment than off it.
Alcohol tends to hit harder on Wegovy. The reasons aren't fully established, but reduced food intake and altered gastric emptying both likely play a role. Most clinicians suggest limiting alcohol during treatment, and some people find they simply want it less. Your prescriber is the right person to talk through specifics, dietary questions that feel clinical rather than general are worth raising at your next review. If you're weighing up how Wegovy compares to other weight-loss treatment options, the evidence behind each approach is worth understanding properly.
NICE recommends semaglutide for a maximum of two years within a specialist weight management service, and a review at six months checks whether at least 5% body weight has been lost before treatment continues. That six-month marker matters from a dietary standpoint too: it's when many people genuinely reassess what their eating patterns look like long-term, not just what they can tolerate right now.
The goal of a Wegovy treatment plan isn't a temporary diet bolted onto an injection. The behavioural changes around food (eating slowly, stopping when satisfied, prioritising protein and vegetables, staying hydrated) are the ones that persist after treatment ends. Evidence from clinical trials consistently shows that weight is partially regained when the medicine is stopped without sustained lifestyle change. That's not a criticism; it reflects how biology responds to GLP-1 medicines, and it's honest.
How long treatment runs, whether and how it's tapered, and what comes next are all questions for your prescriber, not a general article. The treatment duration page covers what the guidance says about how long a Wegovy course typically runs. If you're at the stage of thinking about the process from the beginning, the Wegovy overview and weight-loss treatment guide both set out the full picture, what the medicine is, who it's for, and the access routes available in the UK.
For people considering private treatment, a regulated, clinician-led service means dietary and side-effect questions go to a real prescriber, not a FAQ page. Patients based in the area can read more about how wegovy treatment in Essex is delivered through our service, including what the consultation process involves. Those wanting a broader overview of the active ingredient can find detail on what semaglutide treatment involves and how it works before booking. At the end of your consultation with our team, there's space to raise exactly these questions. Speak to our prescribers if you're ready to take the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.